BioLife Solutions Stock

BioLife Solutions EBIT

The EBIT of BioLife Solutions (BLFS) as of Jul 16, 2026 is -1.08 M USD. In the previous year, EBIT was -4.48 M USD — a change of -75.85% (higher).

EBIT

-1.08 MUSD

YoY

-75.85%

Last updated:

In 2026, BioLife Solutions's EBIT was -1.08 M USD, a -75.85% increase from the -4.48 M USD EBIT recorded in the previous year.

The BioLife Solutions EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2024
-4.48 base
Jan 1, 2025
-1.08 base
Jan 1, 2026 (e)
5.27 base
Jan 1, 2027 (e)
15.30 base
Jan 1, 2028 (e)
36.15 base
Jan 1, 2029 (e)
45.33 base
Jan 1, 2030 (e)
70.36 base
Jan 1, 2031 (e)
0.00 base
YEAREBIT (M USD)
2031 est -
2030 est 70.36
2029 est 45.33
2028 est 36.15
2027 est 15.30
2026 est 5.27
2025 -1.08
2024 -4.48
2023 -17.21
2022 -35.10
2021 -33.50
2020 -5.50
2019 0.70
2018 3.70
2017 -1.10
2016 -4.90
2015 -5.00
2014 -3.10
2013 -0.30
2012 -0.90
2011 -1.20
2010 -1.40
2009 -1.90
2008 -2.20
2007 -2.50
2006 -1.50
Access this data via the Eulerpool API

BioLife Solutions Revenue

BioLife Solutions Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
74.65 M USD
-4.48 M USD
-20.18 M USD
Jan 1, 2025
96.21 M USD
-1.08 M USD
-4.60 M USD
Jan 1, 2026 (e)
115.20 M USD
5.27 M USD
7.14 M USD
Jan 1, 2027 (e)
135.73 M USD
15.30 M USD
19.73 M USD
Jan 1, 2028 (e)
164.95 M USD
36.15 M USD
41.40 M USD
Jan 1, 2029 (e)
200.57 M USD
45.33 M USD
41.40 M USD
Jan 1, 2030 (e)
247.70 M USD
70.36 M USD
56.02 M USD
Jan 1, 2031 (e)
310.03 M USD
0.00 USD
0.00 USD

BioLife Solutions Margins

BioLife Solutions stock margins

The BioLife Solutions margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioLife Solutions. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioLife Solutions.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2024
67.11 %
-6.00 %
-27.04 %
Jan 1, 2025
64.56 %
-1.12 %
-4.78 %
Jan 1, 2026 (e)
64.56 %
4.57 %
6.20 %
Jan 1, 2027 (e)
64.56 %
11.27 %
14.53 %
Jan 1, 2028 (e)
64.56 %
21.92 %
25.10 %
Jan 1, 2029 (e)
64.56 %
22.60 %
20.64 %
Jan 1, 2030 (e)
64.56 %
28.41 %
22.61 %
Jan 1, 2031 (e)
64.56 %
0.00 %
0.00 %

BioLife Solutions Stock analysis

What does BioLife Solutions do? BioLife Solutions Inc. was founded in 1998 and has since been continuously working on the development and production of bioproducts. The company is based in Bothell, Washington and employs over 50 staff members. BioLife Solutions specializes in the development of biological storage and transportation solutions, offering innovative products and services to companies in the biotechnology, cell therapy, and regenerative medicine sectors. The business model of BioLife Solutions is based on the sale of cryopreservation media and devices for packaging and storing biological materials. The company offers a wide range of products and services, including bioproducts, cryopreservation media, cell transport containers, and automatic freezers. These products allow companies in the biotechnology, cell therapy, and regenerative medicine industries to safely and effectively transport and store their products, contributing to increased product quality. BioLife Solutions works with leading biotechnology companies, cell therapy centers, and scientific institutions. The company has a strong network in the industry and is able to offer customized solutions to meet specific customer requirements. BioLife Solutions prides itself on not only providing biological products and devices to its customers but also offering expert advice and support in product selection and service. BioLife Solutions offers various divisions, such as cryopreservation media, cell transport containers, and automatic freezers. The cryopreservation media are typically mixed with cells before being frozen and stored. The special media ensure that the cells maintain their biological properties during storage and can be reactivated when needed. BioLife Solutions' cell transport containers are designed to safely transport cells without damage. These containers are available in different sizes and shapes and ensure the safe transport of cells and tissues worldwide. BioLife Solutions' automatic freezers are equipped with an intelligent system that automates the storage and management of biological materials. The products are designed to meet specific customer requirements and contribute to increased product quality. In terms of products, BioLife Solutions offers a wide range of innovative solutions. One of its most well-known products is CryoStor, a cryopreservation media frequently used in cell storage and transport. CryoStor allows companies to store and transport their cells safely and effectively. BioLife Solutions has also developed an automatic cell storage device called SmartStore, which is capable of automatically storing and monitoring biological materials. SmartStore provides an intelligent and user-friendly solution for the automatic storage of biological materials and contributes to improved product quality. BioLife Solutions' mission is to offer innovative biological products and solutions that contribute to improved product quality and simplified biological research and therapy. The company continues to strive for the development of products that meet specific customer requirements and help improve the biotechnology industry. BioLife Solutions is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing BioLife Solutions's EBIT

BioLife Solutions's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of BioLife Solutions's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

BioLife Solutions's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in BioLife Solutions’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about BioLife Solutions stock

EBIT of BioLife Solutions is -1.08 M USD in 2026.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — BioLife Solutions

All Key Metrics — BioLife Solutions